All Stories

  1. Long‐term preservation of kidney function with SGLT‐2 inhibitors versus comparator drugs in people with type 2 diabetes and chronic kidney disease

    Article • Diabetes Obesity and Metabolism, July 2025, Wiley

    Prof Marco Giorgio Baroni

  2. Effects of gender affirming hormone therapy with testosterone on renal function of assigned female at birth transgender people: a meta-analysis

    Article • Frontiers in Endocrinology, June 2025, Frontiers

    Prof Marco Giorgio Baroni

  3. Real-World Analysis of Short-Term Effectiveness of Oral Semaglutide: Impact on Glycometabolic Control and Cardiovascular Risk

    Article • Pharmaceuticals, June 2025, MDPI AG

    Prof Marco Giorgio Baroni

  4. Association Between Active DNA Demethylation and Liver Fibrosis in Individuals with Metabolic-Associated Steatotic Liver Disease (MASLD)

    Article • International Journal of Molecular Sciences, January 2025, MDPI AG

    Prof Marco Giorgio Baroni

  5. Does irisin mediate metabolic effects of androgen deficiency? A cross-sectional study in men with chronic spinal cord injury

    Article • Spinal Cord, December 2024, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  6. Association Between Active DNA Demethylation and Liver Fibrosis in Individuals with Metabolic‐ Associated Steatotic Liver Disease (MASLD)

    Article • December 2024, MDPI AG

    Prof Marco Giorgio Baroni

  7. Circulating Proneurotensin Levels Predict Impaired Bone Mineralisation in Postmenopausal Women With Type 2 Diabetes Mellitus

    Article • Diabetes/Metabolism Research and Reviews, December 2024, Wiley

    Prof Marco Giorgio Baroni

  8. Metabolic Features of Assigned Female at Birth Transgender People on Gender-Affirming Hormone Therapy: A Meta-analysis

    Article • Transgender Health, December 2024, Mary Ann Liebert Inc

    Prof Marco Giorgio Baroni

  9. Waist circumference, among metabolic syndrome components, predicts degraded trabecular bone score: a retrospective study of a female population from the 2005-2008 NHANES cohorts

    Article • Frontiers in Endocrinology, November 2024, Frontiers

    Prof Marco Giorgio Baroni

  10. Short-Term Changes in Bone Metabolism Among Transgender Men Starting Gender-Affirming Hormone Therapy: A Systematic Review and Meta-analysis

    Article • Calcified Tissue International, October 2024, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  11. Biochemical liver damage during gender affirming therapy in trans adults assigned female at birth: a meta-analysis

    Article • Journal of Endocrinological Investigation, June 2024, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  12. Oral Semaglutide in Routine Clinical Practice: Characteristics of People with Type 2 Diabetes Started on the Drug and Changes in Their Clinical Parameters after 24 Weeks of Treatment

    Article • Journal of Clinical Medicine, May 2024, MDPI AG

    Prof Marco Giorgio Baroni

  13. Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk

    Article • The Lancet Regional Health - Europe, March 2024, Elsevier

    Prof Marco Giorgio Baroni

  14. Correlates of metabolic syndrome in people with chronic spinal cord injury

    Article • Journal of Endocrinological Investigation, January 2024, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  15. MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus

    Article • Diabetes & Metabolism, January 2024, Elsevier

    Prof Marco Giorgio Baroni

  16. Iodine Intake and Testosterone

    Article • JAMA Network Open, December 2023, American Medical Association (AMA)

    Prof Marco Giorgio Baroni

  17. Reduced Lipopolysaccharide-Binding Protein (LBP) Levels Are Associated with Non-Alcoholic Fatty Liver Disease (NAFLD) and Adipose Inflammation in Human Obesity

    Article • International Journal of Molecular Sciences, December 2023, MDPI AG

    Prof Marco Giorgio Baroni

  18. Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus

    Article • Diabetes & Metabolism, November 2023, Elsevier

    Prof Marco Giorgio Baroni

  19. Validation in type 2 diabetes of a metabolomic signature of all‐cause mortality

    Article • Diabetes/Metabolism Research and Reviews, October 2023, Wiley

    Prof Marco Giorgio Baroni

  20. Intelligent Insulin vs. Artificial Intelligence for Type 1 Diabetes: Will the Real Winner Please Stand Up?

    Article • International Journal of Molecular Sciences, August 2023, MDPI AG

    Prof Marco Giorgio Baroni

  21. Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus

    Article • Cardiovascular Diabetology, August 2023, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  22. Effect of antioxidants on semen parameters in men with oligo‐astheno‐teratozoospermia: a network meta‐analysis

    Article • Andrology, July 2023, Wiley

    Prof Marco Giorgio Baroni

  23. Glycated haemoglobin in the first year after diagnosis of type 1 diabetes is an independent risk factor for diabetic retinopathy: The IMDIAB 25 years follow‐up study

    Article • Diabetes Obesity and Metabolism, July 2023, Wiley

    Prof Marco Giorgio Baroni

  24. Clinical Correlates of Metabolic Syndrome in Men with Spinal Cord Injury

    Article • June 2023, MDPI AG

    Prof Marco Giorgio Baroni

  25. Independent association of hypovitaminosis d with non-alcoholic fatty liver disease in people with chronic spinal cord injury: a cross-sectional study

    Article • Journal of Endocrinological Investigation, June 2023, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  26. Neurotensin Gene rs2234762 C>G Variant Associates with Reduced Circulating Pro-NT Levels and Predicts Lower Insulin Resistance in Overweight/Obese Children

    Article • International Journal of Molecular Sciences, March 2023, MDPI AG

    Prof Marco Giorgio Baroni

  27. Reduced High-Density Lipoprotein Cholesterol Is an Independent Determinant of Altered Bone Quality in Women with Type 2 Diabetes

    Article • International Journal of Molecular Sciences, March 2023, MDPI AG

    Prof Marco Giorgio Baroni

  28. Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes

    Article • Diabetes/Metabolism Research and Reviews, March 2023, Wiley

    Prof Marco Giorgio Baroni

  29. Sex Differences in Cardiovascular Disease and Cardiovascular Risk Estimation in Patients With Type 1 Diabetes

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2023, Endocrine Society

    Prof Marco Giorgio Baroni

  30. A sub-analysis of the SAGE study in Italy indicates good glycemic control in type 1 diabetes

    Article • Nutrition Metabolism and Cardiovascular Diseases, March 2023, Elsevier

    Prof Marco Giorgio Baroni

  31. Selective modulation of estrogen receptor in obese men with androgen deficiency: A systematic review and meta‐analysis

    Article • Andrology, January 2023, Wiley

    Prof Marco Giorgio Baroni

  32. Body mass index versus surrogate measures of central adiposity as independent predictors of mortality in type 2 diabetes

    Article • Cardiovascular Diabetology, December 2022, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  33. Infection rate of penile prosthesis implants in men with spinal cord injury: a meta-analysis of available evidence

    Article • International Journal of Impotence Research, October 2022, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  34. Contribution of rare variants in monogenic diabetes-genes to early-onset type 2 diabetes

    Article • Diabetes & Metabolism, September 2022, Elsevier

    Prof Marco Giorgio Baroni

  35. Uric acid versus metabolic syndrome as markers of fatty liver disease in young people with overweight/obesity

    Article • Diabetes/Metabolism Research and Reviews, July 2022, Wiley

    Prof Marco Giorgio Baroni

  36. Semaglutide in routine clinical practice: interesting news from real-world evidence

    Article • Journal of Endocrinological Investigation, May 2022, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  37. Association between urinary bisphenol A concentrations and semen quality: A meta-analytic study

    Article • Biochemical Pharmacology, March 2022, Elsevier

    Prof Marco Giorgio Baroni

  38. Chronic urticaria and thyroid autoimmunity: a meta-analysis of case–control studies

    Article • Journal of Endocrinological Investigation, February 2022, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  39. New Insights in the Control of Fat Homeostasis: The Role of Neurotensin

    Article • International Journal of Molecular Sciences, February 2022, MDPI AG

    Prof Marco Giorgio Baroni

  40. Pathogenic variants of MODY-genes in adult patients with early-onset type 2 diabetes

    Article • Acta Diabetologica, February 2022, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  41. Deep Resequencing of 9 Candidate Genes Identifies a Role for ARAP1 and IGF2BP2 in Modulating Insulin Secretion Adjusted for Insulin Resistance in Obese Southern Europeans

    Article • International Journal of Molecular Sciences, January 2022, MDPI AG

    Prof Marco Giorgio Baroni

  42. Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study

    Article • Frontiers in Endocrinology, November 2021, Frontiers

    Prof Marco Giorgio Baroni

  43. Prevalence of Mildly Reduced Estimated GFR by Height- or Age-Related Equations in Young People With Obesity and Its Association with Cardiometabolic Risk Factors

    Article • Journal of Renal Nutrition, November 2021, Elsevier

    Prof Marco Giorgio Baroni

  44. Biliverdin reductase-A protein levels are reduced in type 2 diabetes and are associated with poor glycometabolic control

    Article • Life Sciences, November 2021, Elsevier

    Prof Marco Giorgio Baroni

  45. Cardiovascular risk reduction throughout GLP-1 receptor agonist and SGLT2 inhibitor modulation of epicardial fat

    Article • Journal of Endocrinological Investigation, October 2021, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  46. The rs45454496 (E1813K) variant in the adiposity gene ANK2 doesn't associate with obesity in Southern European subjects

    Article • Gene Reports, September 2021, Elsevier

    Prof Marco Giorgio Baroni

  47. High pro-neurotensin levels in individuals with type 1 diabetes associate with the development of cardiovascular risk factors at follow-up

    Article • Acta Diabetologica, August 2021, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  48. Erectile dysfunction in hyperuricemia: A prevalence meta‐analysis and meta‐regression study

    Article • Andrology, August 2021, Wiley

    Prof Marco Giorgio Baroni

  49. A long-term nationwide study on chronic kidney disease-related mortality in Italy: trends and associated comorbidity

    Article • Journal of Nephrology, August 2021, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  50. The single-point insulin sensitivity estimator (SPISE) index is a strong predictor of abnormal glucose metabolism in overweight/obese children: a long-term follow-up study

    Article • Journal of Endocrinological Investigation, June 2021, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  51. Circulating pro-neurotensin levels predict bodyweight gain and metabolic alterations in children

    Article • Nutrition Metabolism and Cardiovascular Diseases, March 2021, Elsevier

    Prof Marco Giorgio Baroni

  52. Uric acid, impaired fasting glucose and impaired glucose tolerance in youth with overweight and obesity

    Article • Nutrition Metabolism and Cardiovascular Diseases, February 2021, Elsevier

    Prof Marco Giorgio Baroni

  53. Independent association of atherogenic dyslipidaemia with all‐cause mortality in individuals with type 2 diabetes and modifying effect of gender: a prospective cohort study

    Article • Cardiovascular Diabetology, January 2021, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  54. Effects of work status changes and perceived stress on glycaemic control in individuals with type 1 diabetes during COVID-19 lockdown in Italy

    Article • Diabetes Research and Clinical Practice, December 2020, Elsevier

    Prof Marco Giorgio Baroni

  55. Reduced Biliverdin Reductase-A Expression in Visceral Adipose Tissue is Associated with Adipocyte Dysfunction and NAFLD in Human Obesity

    Article • International Journal of Molecular Sciences, November 2020, MDPI AG

    Prof Marco Giorgio Baroni

  56. Granzyme B Expression in Visceral Adipose Tissue Associates With Local Inflammation and Glyco-Metabolic Alterations in Obesity

    Article • Frontiers in Immunology, November 2020, Frontiers

    Prof Marco Giorgio Baroni

  57. Angiopoietin-Like Protein 4 Overexpression in Visceral Adipose Tissue from Obese Subjects with Impaired Glucose Metabolism and Relationship with Lipoprotein Lipase

    Article • International Journal of Molecular Sciences, September 2020, MDPI AG

    Dr Amalia Gastaldelli, Prof Marco Giorgio Baroni

  58. Elevated blood pressure, cardiometabolic risk and target organ damage in youth with overweight and obesity

    Article • Nutrition Metabolism and Cardiovascular Diseases, September 2020, Elsevier

    Prof Marco Giorgio Baroni

  59. Association of Apelin Levels in Overweight-obese Children with Pubertal Development, but Not with Insulin Sensitivity: 6.5 Years Follow up Evaluation

    Article • Endocrine Research, August 2020, Taylor & Francis

    Prof Marco Giorgio Baroni

  60. Adipose tissue remodelling in obese subjects is a determinant of presence and severity of fatty liver disease

    Article • Diabetes/Metabolism Research and Reviews, July 2020, Wiley

    Prof Marco Giorgio Baroni

  61. COVID-19 and diabetes: Is this association driven by the DPP4 receptor? Potential clinical and therapeutic implications

    Article • Diabetes Research and Clinical Practice, May 2020, Elsevier

    Prof Marco Giorgio Baroni

  62. GLP-1 Receptor Agonists and SGLT2 Inhibitors for the Treatment of Type 2 Diabetes: New Insights and Opportunities for Cardiovascular Protection

    Article • January 2020, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  63. High uric acid, reduced glomerular filtration rate and non-alcoholic fatty liver in young people with obesity

    Article • Journal of Endocrinological Investigation, October 2019, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  64. Greater circulating DPP4 activity is associated with impaired flow-mediated dilatation in adults with type 2 diabetes mellitus

    Article • Nutrition Metabolism and Cardiovascular Diseases, October 2019, Elsevier

    Prof Marco Giorgio Baroni

  65. The American Academy of Pediatrics hypertension guidelines identify obese youth at high cardiovascular risk among individuals non-hypertensive by the European Society of Hypertension guidelines

    Article • European Journal of Preventive Cardiology, August 2019, SAGE Publications

    giuliana valerio, Prof Marco Giorgio Baroni

  66. Reduced biliverdin reductase-A levels are associated with early alterations of insulin signaling in obesity

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, June 2019, Elsevier

    Prof Marco Giorgio Baroni

  67. Sick fat: the good and the bad of old and new circulating markers of adipose tissue inflammation

    Article • Journal of Endocrinological Investigation, May 2019, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  68. Testing for type 1 diabetes autoantibodies in gestational diabetes mellitus (GDM): is it clinically useful?

    Article • BMC Endocrine Disorders, May 2019, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  69. Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study

    Article • BMC Medicine, April 2019, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  70. Impact of the 2017 Blood Pressure Guidelines by the American Academy of Pediatrics in overweight/obese youth

    Article • Journal of Hypertension, April 2019, Wolters Kluwer Health

    Prof Marco Giorgio Baroni

  71. Circulating miRNA-375 levels are increased in autoantibodies-positive first-degree relatives of type 1 diabetes patients

    Article • Acta Diabetologica, February 2019, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  72. ANGPTL4 gene E40K variation protects against obesity‐associated dyslipidemia in participants with obesity

    Article • Obesity Science & Practice, December 2018, Wiley

    Prof Marco Giorgio Baroni

  73. Preclinical signs of liver and cardiac damage in youth with metabolically healthy obese phenotype

    Article • Nutrition Metabolism and Cardiovascular Diseases, December 2018, Elsevier

    Prof Marco Giorgio Baroni

  74. Variability in genes regulating vitamin D metabolism is associated with vitamin D levels in type 2 diabetes

    Article • Oncotarget, September 2018, Impact Journals, LLC

    Prof Marco Giorgio Baroni

  75. Impaired bone matrix glycoprotein pattern is associated with increased cardio-metabolic risk profile in patients with type 2 diabetes mellitus

    Article • Journal of Endocrinological Investigation, August 2018, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  76. Procollagen-III peptide identifies adipose tissue-associated inflammation in type 2 diabetes with or without nonalcoholic liver disease

    Article • Diabetes/Metabolism Research and Reviews, March 2018, Wiley

    Prof Marco Giorgio Baroni

  77. Presence of diabetes-specific autoimmunity in women with gestational diabetes mellitus (GDM) predicts impaired glucose regulation at follow-up

    Article • Journal of Endocrinological Investigation, January 2018, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  78. The Arg282Ser missense mutation in APOA5 gene determines a reduction of triglyceride and LDL-cholesterol in children, together with low serum levels of apolipoprotein A-V

    Article • Lipids in Health and Disease, September 2017, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  79. A new index to simplify the screening of hypertension in overweight or obese youth

    Article • Nutrition Metabolism and Cardiovascular Diseases, September 2017, Elsevier

    Prof Marco Giorgio Baroni

  80. Comment on Elangovan H et al. vitamin D in liver disease: Current evidence and potential directions. Biochim Biophys Acta 2017;1863(4):907–916

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, September 2017, Elsevier

    Prof Marco Giorgio Baroni

  81. Circulating IL-8 levels are increased in patients with type 2 diabetes and associated with worse inflammatory and cardiometabolic profile

    Article • Acta Diabetologica, August 2017, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  82. Silent coronary heart disease in patients with type 2 diabetes: application of a screening approach in a follow-up study

    Article • Journal of Diabetes and its Complications, June 2017, Elsevier

    Prof Marco Giorgio Baroni

  83. WISP1 Is a Marker of Systemic and Adipose Tissue Inflammation in Dysmetabolic Subjects With or Without Type 2 Diabetes

    Article • Journal of the Endocrine Society, April 2017, Endocrine Society

    Fabrizio Mainiero, Prof Marco Giorgio Baroni

  84. The vitamin D receptor functional variant rs2228570 (C>T) does not associate with type 2 diabetes mellitus

    Article • Endocrine Research, April 2017, Taylor & Francis

    Prof Marco Giorgio Baroni

  85. Childhood obesity classification systems and cardiometabolic risk factors: a comparison of the Italian, World Health Organization and International Obesity Task Force references

    Article • Italian Journal of Pediatrics, February 2017, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  86. Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease

    Article • World Journal of Gastroenterology, January 2017, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Prof Marco Giorgio Baroni

  87. High prevalence of diabetes-specific autoimmunity in first-degree relatives of Sardinian patients with type 1 diabetes

    Article • Diabetes/Metabolism Research and Reviews, November 2016, Wiley

    Prof Marco Giorgio Baroni

  88. Impaired fasting glucose and impaired glucose tolerance in children and adolescents with overweight/obesity

    Article • Journal of Endocrinological Investigation, November 2016, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  89. Severe hypoglycemia in patients with known diabetes requiring emergency department care: A report from an Italian multicenter study

    Article • Journal of Clinical & Translational Endocrinology, September 2016, Elsevier

    Dr. Giorgio Grani, Prof Marco Giorgio Baroni

  90. Phenotypical heterogeneity linked to adipose tissue dysfunction in patients with Type 2 diabetes

    Article • Clinical Science, August 2016, Portland Press Ltd.

    Prof Marco Giorgio Baroni

  91. No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial

    Article • BMC Medicine, June 2016, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  92. Corrigendum to “Comparison of non-HDL-cholesterol versus triglycerides-to-HDLcholesterol ratio in relation to cardiometabolic risk factors and preclinical organ damage in overweight/obese children: The CARITALY study” [Nutr Metab Cardiovasc Dis 25 (201...

    Article • Nutrition Metabolism and Cardiovascular Diseases, June 2016, Elsevier

    Prof Marco Giorgio Baroni

  93. White blood cell count may identify abnormal cardiometabolic phenotype and preclinical organ damage in overweight/obese children

    Article • Nutrition Metabolism and Cardiovascular Diseases, June 2016, Elsevier

    Prof Marco Giorgio Baroni

  94. The vitamin D receptor (VDR) gene rs11568820 variant is associated with type 2 diabetes and impaired insulin secretion in Italian adult subjects, and associates with increased cardio-metabolic risk in children

    Article • Nutrition Metabolism and Cardiovascular Diseases, May 2016, Elsevier

    Prof Marco Giorgio Baroni

  95. Effects of Metformin and Exercise Training, Alone or in Combination, on Cardiac Function in Individuals with Insulin Resistance

    Article • Cardiology and Therapy, February 2016, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  96. Search for Genetic Variant in the Apelin Gene by Resequencing and Association Study in European Subjects

    Article • Genetic Testing and Molecular Biomarkers, February 2016, Mary Ann Liebert Inc

    Prof Marco Giorgio Baroni

  97. Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly

    Article • Nutrition Metabolism and Cardiovascular Diseases, February 2016, Elsevier

    Prof Marco Giorgio Baroni

  98. The “Sapienza University Mortality and Morbidity Event Rate (SUMMER) study in diabetes”: Study protocol

    Article • Nutrition Metabolism and Cardiovascular Diseases, February 2016, Elsevier

    Prof Marco Giorgio Baroni

  99. Transmembrane-6 superfamily member 2 (TM6SF2) E167K variant increases susceptibility to hepatic steatosis in obese children

    Article • Digestive and Liver Disease, January 2016, Elsevier

    Prof Marco Giorgio Baroni

  100. Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing’s syndrome and acromegaly

    Article • Journal of Endocrinological Investigation, December 2015, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  101. Increased circulating osteopontin levels in adult patients with type 1 diabetes mellitus and association with dysmetabolic profile

    Article • November 2015, Bioscientifica

    Prof Marco Giorgio Baroni

  102. The perilipin 2 (PLIN2) gene Ser251Pro missense mutation is associated with reduced insulin secretion and increased insulin sensitivity in Italian obese subjects

    Article • Diabetes/Metabolism Research and Reviews, November 2015, Wiley

    Prof Marco Giorgio Baroni

  103. Comparison of non-HDL-cholesterol versus triglycerides-to-HDL-cholesterol ratio in relation to cardiometabolic risk factors and preclinical organ damage in overweight/obese children: The CARITALY study

    Article • Nutrition Metabolism and Cardiovascular Diseases, May 2015, Elsevier

    Prof Marco Giorgio Baroni

  104. Continuous Subcutaneous Insulin Infusion in Italy: Third National Survey

    Article • Diabetes Technology & Therapeutics, February 2015, Mary Ann Liebert Inc

    Dr Antonio C Bossi, Prof Marco Giorgio Baroni

  105. Positive effects of Nordic Walking on anthropometric and metabolic variables in women with type 2 diabetes mellitus

    Article • Science & Sports, February 2015, Elsevier

    Prof Marco Giorgio Baroni

  106. Resistant hypertension in patients with type 2 diabetes

    Article • Journal of Hypertension, December 2014, Wolters Kluwer Health

    Prof Marco Giorgio Baroni

  107. Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2...

    Article • The Lancet Diabetes & Endocrinology, November 2014, Elsevier

    Prof Marco Giorgio Baroni

  108. Chronic kidney disease in type 2 diabetes: Lessons from the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study

    Article • Nutrition Metabolism and Cardiovascular Diseases, August 2014, Elsevier

    Prof Marco Giorgio Baroni

  109. Anterior pituitary autoantibodies in patients with type 1 diabetes mellitus: methodological problems and clinical correlations

    Article • Journal of Endocrinological Investigation, July 2014, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  110. TSH levels are associated with vitamin D status and seasonality in an adult population of euthyroid adults

    Article • Clinical and Experimental Medicine, June 2014, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  111. Glycated hemoglobin for the diagnosis of diabetes and prediabetes: Diagnostic impact on obese and lean subjects, and phenotypic characterization

    Article • Journal of Diabetes Investigation, May 2014, Wiley

    Prof Marco Giorgio Baroni

  112. High normal post-load plasma glucose, cardiometabolic risk factors and signs of organ damage in obese children

    Article • Obesity, May 2014, Wiley

    Prof Marco Giorgio Baroni, giuliana valerio

  113. Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) It...

    Article • Cardiovascular Diabetology, January 2014, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  114. Effects of metformin and exercise training, alone or in association, on cardio-pulmonary performance and quality of life in insulin resistance patients

    Article • Cardiovascular Diabetology, January 2014, Springer Science + Business Media

    Dr Martino Deidda, Prof Marco Giorgio Baroni

  115. Hypovitaminosis D is Independently Associated with Metabolic Syndrome in Obese Patients

    Article • PLOS One, July 2013, PLOS

    Prof Marco Giorgio Baroni

  116. Relationship between high values of HOMA-IR and cardiovascular response to metformin

    Article • International Journal of Cardiology, July 2013, Elsevier

    Dr Martino Deidda, Prof Marco Giorgio Baroni

  117. The COBLL1 C allele is associated with lower serum insulin levels and lower insulin resistance in overweight and obese children

    Article • Diabetes/Metabolism Research and Reviews, July 2013, Wiley

    Prof Marco Giorgio Baroni

  118. Intensive Structured Self-Monitoring of Blood Glucose and Glycemic Control in Noninsulin-Treated Type 2 Diabetes: The PRISMA randomized trial

    Article • Diabetes Care, June 2013, American Diabetes Association

    Prof Marco Giorgio Baroni

  119. Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study

    Article • Journal of Internal Medicine, April 2013, Wiley

    Prof Marco Giorgio Baroni

  120. TheIRS1rs2943641 Variant and Risk of Future Cancer Among Morbidly Obese Individuals

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2013, Endocrine Society

    Prof Marco Giorgio Baroni

  121. HbA1c Variability as an Independent Correlate of Nephropathy, but Not Retinopathy, in Patients With Type 2 Diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study

    Article • Diabetes Care, March 2013, American Diabetes Association

    Prof Marco Giorgio Baroni

  122. Early impairment of contractility reserve in patients with insulin resistance in comparison with healthy subjects

    Article • Cardiovascular Diabetology, January 2013, Springer Science + Business Media

    Dr Martino Deidda, Prof Marco Giorgio Baroni

  123. Association of RXR-Gamma Gene Variants with Familial Combined Hyperlipidemia: Genotype and Haplotype Analysis

    Article • Journal of Lipids, January 2013, Hindawi Publishing Corporation

    Prof Marco Giorgio Baroni

  124. Altered Glucose Homeostasis Is Associated with Increased Serum Apelin Levels in Type 2 Diabetes Mellitus

    Article • PLOS One, December 2012, PLOS

    Prof Marco Giorgio Baroni

  125. PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individuals

    Article • Digestive and Liver Disease, December 2012, Elsevier

    Prof Marco Giorgio Baroni

  126. Cardiopulmonary and endothelial effects of metformin treatment in an insulin resistant population

    Article • International Journal of Cardiology, July 2012, Elsevier

    Dr Martino Deidda, Prof Marco Giorgio Baroni

  127. Sequential Intensification of Metformin Treatment in Type 2 Diabetes With Liraglutide Followed by Randomized Addition of Basal Insulin Prompted by A1C Targets

    Article • Diabetes Care, May 2012, American Diabetes Association

    Dr Antonio C Bossi, Prof Marco Giorgio Baroni

  128. Association ofFTOPolymorphisms with Early Age of Obesity in Obese Italian Subjects

    Article • Experimental Diabetes Research, January 2012, Hindawi Publishing Corporation

    Prof Marco Giorgio Baroni

  129. Clinical significance of nonalbuminuric renal impairment in type 2 diabetes

    Article • Journal of Hypertension, September 2011, Wolters Kluwer Health

    Prof Marco Giorgio Baroni

  130. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation provides a better definition of cardiovascular burden associated with CKD than the Modification of Diet in Renal Disease (MDRD) Study formula in subjects with type 2 diabetes

    Article • Atherosclerosis, September 2011, Elsevier

    Prof Marco Giorgio Baroni

  131. Prevalence of Type 1 diabetes autoantibodies (GAD and IA2) in Sardinian children and adolescents with autoimmune thyroiditis

    Article • Diabetic Medicine, July 2011, Wiley

    Prof Marco Giorgio Baroni

  132. Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes

    Article • BMC Medicine, July 2011, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  133. Lack of effect of apolipoprotein C3 polymorphisms on indices of liver steatosis, lipid profile and insulin resistance in obese Southern Europeans

    Article • Lipids in Health and Disease, January 2011, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  134. Angiopoietin-like 4 protein (ANGPTL4) E40K protects from developing the atherogenic lipid profile ass in obese individuals

    Article • Atherosclerosis, November 2010, Elsevier

    Prof Marco Giorgio Baroni

  135. The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life

    Article • Journal of Hepatology, August 2010, Elsevier

    Prof Marco Giorgio Baroni

  136. Clinical application of best practice guidelines for the genetic diagnosis of MODY2 and MODY3

    Article • Diabetic Medicine, July 2010, Wiley

    Prof Marco Giorgio Baroni

  137. Unravelling the pathogenesis of fatty liver disease: patatin-like phospholipase domain-containing 3 protein

    Article • Current Opinion in Lipidology, June 2010, Wolters Kluwer Health

    Prof Marco Giorgio Baroni

  138. Analysis of TBC1D4 in patients with severe insulin resistance

    Article • Diabetologia, March 2010, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  139. Homozygosity for the Ala Allele of the PPARγ2 Pro12Ala Polymorphism Is Associated with Reduced Risk of Coronary Artery Disease

    Article • Disease Markers, January 2010, Hindawi Publishing Corporation

    Prof Marco Giorgio Baroni

  140. Prevalence of Type 1 Diabetes Autoantibodies (GADA, IA2, and IAA) in Overweight and Obese Children

    Article • Diabetes Care, December 2009, American Diabetes Association

    Prof Marco Giorgio Baroni

  141. Serum adiponectin is decreased in patients with familial combined hyperlipidemia and normolipaemic relatives and is influenced by lipid-lowering treatment

    Article • Nutrition Metabolism and Cardiovascular Diseases, November 2009, Elsevier

    Prof Marco Giorgio Baroni

  142. Subclinical vascular alterations in young adults with type 1 diabetes detected by arterial tonometry

    Article • Diabetes/Metabolism Research and Reviews, November 2009, Wiley

    Prof Marco Giorgio Baroni

  143. Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent

    Article • International Journal of Obesity, October 2009, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  144. Oral glucose tolerance test in Italian overweight/obese children and adolescents results in a very high prevalence of impaired fasting glycaemia, but not of diabetes

    Article • Diabetes/Metabolism Research and Reviews, September 2009, Wiley

    Prof Marco Giorgio Baroni

  145. MODY-like diabetes associated with an apparently balanced translocation: possible involvement of MPP7 gene and cell polarity in the pathogenesis of diabetes

    Article • Molecular Cytogenetics, January 2009, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  146. Minutes of The 43rd General Assembly of The European Association for The Study of Diabetes

    Article • Diabetologia, August 2008, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  147. Assessment of Adiponectin and Leptin as Biomarkers of Positive Metabolic Outcomes after Lifestyle Intervention in Overweight and Obese Children

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2008, Endocrine Society

    Prof Marco Giorgio Baroni

  148. Insulinoma CM cell line as in vitro model for beta-cell

    Article • Journal of Cellular Physiology, January 2008, Wiley

    Prof Marco Giorgio Baroni

  149. Search for genetic variants of the SYNTAXIN 1A (STX1A) gene: the −352 A>T variant in the STX1A promoter associates with impaired glucose metabolism in an Italian obese population

    Article • International Journal of Obesity, October 2007, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  150. Aminotransferase activity in morbid and uncomplicated obesity: Predictive role of fasting insulin

    Article • Nutrition Metabolism and Cardiovascular Diseases, July 2007, Elsevier

    Prof Marco Giorgio Baroni

  151. Reply to Novelli

    Article • Nutrition Metabolism and Cardiovascular Diseases, March 2007, Elsevier

    Prof Marco Giorgio Baroni

  152. The 3′-UTR C>T polymorphism of the oxidized LDL-receptor 1 (OLR1) gene does not associate with coronary artery disease in Italian CAD patients or with the severity of coronary disease

    Article • Nutrition Metabolism and Cardiovascular Diseases, July 2006, Elsevier

    Prof Marco Giorgio Baroni

  153. The G972R variant of the insulin receptor substrate-1 gene impairs insulin signaling and cell differentiation in 3T3L1 adipocytes; treatment with a PPAR  agonist restores normal cell signaling and differentiation

    Article • Journal of Endocrinology, February 2006, Bioscientifica

    Prof Marco Giorgio Baroni

  154. Complete Clinical Remission and Disappearance of Liver Metastases after Treatment with Somatostatin Analogue in a 40-Year-Old Woman with a Malignant Insulinoma Positive for Somatostatin Receptors Type 2

    Article • Hormone Research in Paediatrics, January 2006, Karger Publishers

    Prof Marco Giorgio Baroni

  155. Article • BMC Genetics, January 2006, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  156. Mo-W4:3 Insulin receptor substrate-1 gene variant in extracoronary atherosclerosis: Evidence for an association with increased risk of ischemic stroke

    Article • Atherosclerosis Supplements, January 2006, Elsevier

    Prof Marco Giorgio Baroni

  157. The adiponectin gene SNP+276G>T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age ≤50 years)

    Article • Journal of Molecular Medicine, May 2005, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  158. The Gly482Ser Missense Mutation of the Peroxisome Proliferator-Activated Receptor γ Coactivator‐1α (PGC‐1α) Gene Associates with Reduced Insulin Sensitivity in Normal and Glucose‐Intolerant Obese Subjects

    Article • Disease Markers, January 2005, Wiley

    Prof Marco Giorgio Baroni

  159. The common PPAR-γ2 Pro12Ala variant is associated with greater insulin sensitivity

    Article • European Journal of Human Genetics, September 2004, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  160. The G972R variant of the insulin receptor substrate-1 (IRS-1) gene is associated with insulin resistance in “uncomplicated” obese subjects evaluated by hyperinsulinemic-euglycemic clamp

    Article • Journal of Endocrinological Investigation, September 2004, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  161. Search for Genetic Variants in the Retinoid X Receptor-γ-Gene by Polymerase Chain Reaction-Single-Strand Conformation Polymorphism in Patients with Resistance to Thyroid Hormone without Mutations in Thyroid Hormone Receptor β Gene

    Article • Thyroid, May 2004, Mary Ann Liebert Inc

    Prof Marco Giorgio Baroni

  162. Association of the human adiponectin gene and insulin resistance

    Article • European Journal of Human Genetics, December 2003, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  163. Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CAD

    Article • BMC Medical Genetics, September 2003, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  164. The Gly972->Arg IRS-1 Variant Is Associated With Type 1 Diabetes in Continental Italy

    Article • Diabetes, March 2003, American Diabetes Association

    Prof Marco Giorgio Baroni

  165. Common variants in the lipoprotein lipase gene, but not those in the insulin receptor substrate[ndash ]1, the [beta ]3-adrenergic receptor, and the intestinal fatty acid binding protein-2 genes, influence the lipid phenotypic expression in familial com...

    Article • Metabolism, October 2002, Elsevier

    Prof Marco Giorgio Baroni

  166. Antibodies to Bovine Beta-Casein in Diabetes and Other Autoimmune Diseases

    Article • Hormone and Metabolic Research, August 2002, Thieme Publishing Group

    Prof Marco Giorgio Baroni

  167. Coronary artery disease and dyslipidemia within Europe: genetic variants in lipid transport gene loci in German subjects with premature coronary artery disease

    Article • Atherosclerosis Supplements, May 2002, Elsevier

    Prof Marco Giorgio Baroni

  168. Human Resistin Gene, Obesity, and Type 2 Diabetes

    Article • Diabetes, March 2002, American Diabetes Association

    Prof Marco Giorgio Baroni

  169. The G-308A variant of the Tumor Necrosis Factor-α (TNF-α) gene is not associated with obesity, insulin resistance and body fat distribution

    Article • BMC Medical Genetics, September 2001, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  170. Single-strand conformation polymorphism analysis of the glucose transporter gene GLUT1 in maturity-onset diabetes of the young

    Article • Journal of Molecular Medicine, April 2001, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  171. The G972R variant of the Insulin Receptor Substrate-1 (IRS-1) gene, body fat distribution and insulin-resistance

    Article • Diabetologia, March 2001, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  172. Common genetic variants that relate to disorders of lipid transport in Spanish subjects with premature coronary artery disease

    Article • Clinical Science, February 2001, Portland Press Ltd.

    Prof Marco Giorgio Baroni

  173. A simple method for non-radioactive PCR-SSCP using MDE™ gel solution and a midi gel format:

    Article • Journal of Biotechnology, March 2000, Elsevier

    Prof Marco Giorgio Baroni

  174. A multi-centre randomized trial of two different doses of nicotinamide in patients with recent-onset Type 1 diabetes (the IMDIAB VI)

    Article • Diabetes/Metabolism Research and Reviews, May 1999, Wiley

    Prof Marco Giorgio Baroni, Alberto Signore

  175. Beta-cell gene expression and functional characterisation of the human insulinoma cell line CM

    Article • Journal of Endocrinology, April 1999, Bioscientifica

    Prof Marco Giorgio Baroni

  176. Prognostic relevance of pancreatic uptake of technetium-99m labelled human polyclonal immunoglobulins in patients with type 1 diabetes

    Article • European Journal of Pediatrics, May 1998, Springer Science + Business Media

    Prof Marco Giorgio Baroni, Alberto Signore

  177. High frequency of polymorphism but no mutations found in the GLUT1 glucose transporter gene in NIDDM and familial obesity by SSCP analysis

    Article • Human Genetics, April 1998, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  178. Insulin VNTR allele-specific effect in type 1 diabetes depends on identity of untransmitted paternal allele

    Article • Nature Genetics, November 1997, Springer Science + Business Media

    Prof Marco Giorgio Baroni, Alberto Signore

  179. 1.W05.2 Eurogeneheart. Genetic determinants of coronary artery disease in the European union

    Article • Atherosclerosis, October 1997, Elsevier

    Prof Marco Giorgio Baroni

  180. Vitamin E and nicotinamide have similar effects in maintaining residual beta cell function in recent onset insulin-dependent diabetes (the IMDIAB IV study)

    Article • European Journal of Endocrinology, September 1997, Bioscientifica

    Prof Marco Giorgio Baroni, Alberto Signore

  181. Genetic contribution of polymorphism of the GLUT1 and GLUT4 genes to the susceptibility to type 2 (non-insulin-dependent) diabetes mellitus in different populations

    Article • Acta Diabetologica, September 1996, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  182. Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study)

    Article • Diabetologia, July 1995, Springer Science + Business Media

    Prof Marco Giorgio Baroni, Alberto Signore

  183. Nicotinamide vs Steroids in Recent-Onset Diabetes: Impact on 3-Cell Function

    Article • Diabetes Care, August 1994, American Diabetes Association

    Alberto Signore, Prof Marco Giorgio Baroni

  184. Affected sib-pair analysis of the GLUT1 glucose transporter gene locus in non-insulin-dependent diabetes mellitus (NIDDM): evidence for no linkage

    Article • Human Genetics, June 1994, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  185. Randomized Trial Comparing Nicotinamide and Nicotinamide Plus Cyclosporin in Recent Onset Insulin-dependent Diabetes (IMDIAB 1)

    Article • Diabetic Medicine, January 1994, Wiley

    Alberto Signore, Prof Marco Giorgio Baroni

  186. Genetic Variation Around the Collagen IV 1a Gene Locus and Proliferative Retinopathy in Type 2 Diabetes mellitus

    Article • Human Heredity, January 1993, Karger Publishers

    Prof Marco Giorgio Baroni

  187. Polymorphisms at the GLUT2 (β‐cell/liver) glucose transporter gene and non‐insulin‐dependent diabetes mellitus (NIDDM): analysis in affected pedigree members

    Article • Clinical Genetics, May 1992, Wiley

    Prof Marco Giorgio Baroni

  188. Polymorphisms at the GLUT1 (HepG2) and GLUT4 (muscle/adipocyte) glucose transporter genes and non-insulin-dependent diabetes mellitus (NIDDM)

    Article • Human Genetics, March 1992, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  189. Restriction Fragment Length Polymorphisms at the GLUT4 and GLUT1 Gene Loci in Type 2 Diabetes

    Article • Diabetic Medicine, January 1992, Wiley

    Prof Marco Giorgio Baroni

  190. Genetic polymorphisms at the human liver/islet glucose transporter (GLUTT2) gene locus in Caucasian and West Indian subjects with type 2 (non-insulin-dependent) diabetes mellitus

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, November 1991, Elsevier

    Prof Marco Giorgio Baroni

  191. Association between a restriction fragment length polymorphism at the liver/islet cell (GluT 2) glucose transporter and familial Type 2 (non-insulin-dependent) diabetes mellitus

    Article • Diabetologia, October 1991, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  192. Insulin receptor gene polymorphisms in Type 2 (non-insulin-dependent) diabetes mellitus

    Article • Diabetologia, April 1991, Springer Science + Business Media

    Prof Marco Giorgio Baroni

  193. Bgl-I and Kpn-I RFLPs at the human liver/islet glucose transporter (GLUT2) gene locus

    Article • Nucleic Acids Research, January 1991, Oxford University Press (OUP)

    Prof Marco Giorgio Baroni

  194. Restriction Site Polymorphisms at the Human HepG2 Glucose Transporter Gene Locus in Caucasian and West Indian Subjects with Non-Insulin-Dependent Diabetes mellitus

    Article • Human Heredity, January 1990, Karger Publishers

    Prof Marco Giorgio Baroni

  195. Ava-II RFLP at the human hepatic lipase (HL) gene locus

    Article • Nucleic Acids Research, January 1989, Oxford University Press (OUP)

    Prof Marco Giorgio Baroni

  196. Stu I RFLP at the human Hep G2/Erythrocyte glucose transporter (GLUT) gene locus

    Article • Nucleic Acids Research, January 1989, Oxford University Press (OUP)

    Prof Marco Giorgio Baroni

  197. ASSOCIATION OF GENETIC VARIANT OF THE GLUCOSE TRANSPORTER WITH NON-INSULIN-DEPENDENT DIABETES MELLITUS

    Article • The Lancet, August 1988, Elsevier

    Prof Marco Giorgio Baroni

  198. The immune response to influenza vaccination in diabetic patients

    Article • Diabetologia, December 1986, Springer Science + Business Media

    Prof Marco Giorgio Baroni